ATC codes:
A04AA01
EMLc
Indication
Palliative care
ICD11 code:
QC7A
INN
Ondansetron
Medicine type
Chemical agent
List type
Core
(EML)
(EMLc)
(EMLc)
Formulations
Parenteral > General injections > IV:
2 mg per mL in 2 mL ampoule (as hydrochloride dihydrate) ;
2 mg per mL in 4 mL ampoule (as hydrochloride dihydrate)
Oral > Liquid: 4 mg per 5 mL (as hydrochloride dihydrate)
Oral > Solid: 4 mg (as hydrochloride dihydrate) ; 8 mg (as hydrochloride dihydrate)
Oral > Liquid: 4 mg per 5 mL (as hydrochloride dihydrate)
Oral > Solid: 4 mg (as hydrochloride dihydrate) ; 8 mg (as hydrochloride dihydrate)
EML status history
Sex
All
Age
Also recommended for children
Therapeutic alternatives
Patent information
Patents have expired in most jurisdictions
Read more
about patents.
Wikipedia
DrugBank
Summary of evidence and Expert Committee recommendations
Following the review of the age-appropriateness of formulations on the EMLc, the Expert Committee recommended:
- the addition of ondansetron injection 2 mg/mL in 4 mL ampoule to the EML and EMLc;
- to modify the formulation descriptions to consistently describe the available dosage forms.